EP3370765A4 - Novel platform dna vaccine - Google Patents

Novel platform dna vaccine Download PDF

Info

Publication number
EP3370765A4
EP3370765A4 EP16863078.8A EP16863078A EP3370765A4 EP 3370765 A4 EP3370765 A4 EP 3370765A4 EP 16863078 A EP16863078 A EP 16863078A EP 3370765 A4 EP3370765 A4 EP 3370765A4
Authority
EP
European Patent Office
Prior art keywords
dna vaccine
novel platform
platform dna
novel
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16863078.8A
Other languages
German (de)
French (fr)
Other versions
EP3370765A1 (en
Inventor
Victor G. SOLODUSHKO
Brian Fouty
Vira BITKO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Alabama
Original Assignee
University of South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Alabama filed Critical University of South Alabama
Priority claimed from PCT/US2016/060631 external-priority patent/WO2017079625A1/en
Publication of EP3370765A1 publication Critical patent/EP3370765A1/en
Publication of EP3370765A4 publication Critical patent/EP3370765A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP16863078.8A 2015-11-06 2016-11-04 Novel platform dna vaccine Withdrawn EP3370765A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562285732P 2015-11-06 2015-11-06
PCT/US2016/060631 WO2017079625A1 (en) 2015-11-06 2016-11-04 Novel platform dna vaccine

Publications (2)

Publication Number Publication Date
EP3370765A1 EP3370765A1 (en) 2018-09-12
EP3370765A4 true EP3370765A4 (en) 2019-06-12

Family

ID=63077614

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16863078.8A Withdrawn EP3370765A4 (en) 2015-11-06 2016-11-04 Novel platform dna vaccine

Country Status (1)

Country Link
EP (1) EP3370765A4 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WU H ET AL: "RSV fusion (F) protein DNA vaccine provides partial protection against viral infection", VIRUS RESEARCH, AMSTERDAM, NL, vol. 145, no. 1, 1 October 2009 (2009-10-01), pages 39 - 47, XP026564433, ISSN: 0168-1702, [retrieved on 20090621], DOI: 10.1016/J.VIRUSRES.2009.06.012 *

Also Published As

Publication number Publication date
EP3370765A1 (en) 2018-09-12

Similar Documents

Publication Publication Date Title
EP3134131A4 (en) Nucleic acid vaccines
EP3322441A4 (en) Vaccine compositions
EP3364981A4 (en) Human cytomegalovirus vaccine
EP3364949A4 (en) Cancer vaccines
EP3188763A4 (en) Methods and compositions for rna-directed target dna modification
EP3102190A4 (en) Novel pharmaceutical formulations
EP3102722A4 (en) Genome fractioning
EP3134427A4 (en) Asx-specific protein ligase
EP3118311A4 (en) Antisense nucleic acid
EP3378394A4 (en) Cloud platform
EP3181982A4 (en) Gimbal platform
GB201518684D0 (en) Vaccine
EP3193888A4 (en) Novel formulations
EP3259032A4 (en) Improved descender
EP3304334A4 (en) Wirelessly connected laboratory
EP3366773A4 (en) Nucleic acid complex
EP3390217A4 (en) Lighter-than-air platform
EP3167060A4 (en) Dna amplification technology
IL266237A (en) Tolerogenic dna vaccine
IL265942A (en) Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine
GB201522132D0 (en) Vaccine
GB201517241D0 (en) DNA modification
EP3373928A4 (en) Novel formulations
EP3228650A4 (en) Novel peg derivative
EP3370765A4 (en) Novel platform dna vaccine

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180503

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190513

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/12 20060101AFI20190507BHEP

Ipc: A61K 39/145 20060101ALI20190507BHEP

Ipc: A61P 33/00 20060101ALI20190507BHEP

Ipc: C12N 7/01 20060101ALI20190507BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200406

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230721